StockNews.com began coverage on shares of ClearOne (NASDAQ:CLRO – Free Report) in a report released on Saturday. The firm issued a hold rating on the communications equipment provider’s stock.
ClearOne Price Performance
NASDAQ:CLRO opened at $0.62 on Friday. The company has a market cap of $14.86 million, a P/E ratio of -8.86 and a beta of 0.80. The stock’s fifty day moving average price is $0.61 and its two-hundred day moving average price is $0.86. ClearOne has a 1 year low of $0.53 and a 1 year high of $2.48.
ClearOne (NASDAQ:CLRO – Get Free Report) last issued its quarterly earnings data on Wednesday, August 14th. The communications equipment provider reported ($0.12) earnings per share (EPS) for the quarter. ClearOne had a negative return on equity of 19.94% and a negative net margin of 22.89%. The business had revenue of $2.30 million during the quarter.
Institutional Inflows and Outflows
About ClearOne
ClearOne, Inc, together with its subsidiaries, designs, develops, and sells conferencing, collaboration, and network streaming solutions for voice and visual communications in the United States and internationally. The company offers a range of audio conferencing products, including professional audio conferencing and sound-reinforcement products for use in enterprise, healthcare, education and distance learning, government, legal, and finance organizations; mid-tier premium conferencing products for smaller rooms, and small and medium businesses, which interface with video and Web conferencing systems; USB-based personal and group speakerphones that could be used with PCs, laptops, tablets, smartphones, and other portable devices; and traditional tabletop conferencing phones used in conference rooms and offices.
See Also
- Five stocks we like better than ClearOne
- Are Penny Stocks a Good Fit for Your Portfolio?
- Why Lennar Stock Could Be the Best Play in the Housing Market
- Most Volatile Stocks, What Investors Need to Know
- 2 Energy Stocks Fueling the AI Datacenter Boom
- What is a Bond Market Holiday? How to Invest and Trade
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for ClearOne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ClearOne and related companies with MarketBeat.com's FREE daily email newsletter.